Piclidenoson Withdrawn Phase 2 Trials for Osteoarthritis of the Knee Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00837291A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee